Breaking

Sunday, November 12, 2017

A hospital cancels IBM Watson artificial intelligence for recommending deadly treatment to cancer patients

A hospital suspends the IBM Watson program after this artificial intelligence recommended to doctors a deadly treatment for cancer patients.


Watson is the artificial intelligence (AI) of IBM that, among other projects, collaborates with the oncology departments of 50 hospitals in 15 countries to help give the best treatment to cancer patients.

However, this AI does not seem to be infallible, as can be seen from what happened at the National Hospital of Denmark. There, Watson recommended the use of a medication that would have caused death to cancer patients in the center.

"We have seen that Watson has proposed a treatment with substances that the patient should never again take, due to the vital risk involved," explained Leif Panduro Jensen, director of the Department of Oncology at the Danish hospital.

"The doctors contrasted the answers with the situation of 31 patients who had already received treatment. In two thirds, they agreed with the treatment recommended by Watson. However, in a third of the cases the proposed treatment was crazy, "he reiterated.

For this reason, the hospital suspended cooperation with IBM Watson only in oncological treatments, but not in other medical areas of the hospital.

IBM Watson is an artificial intelligence program with which the technology company collaborates with 50 hospitals around the world to fight cancers of the breast, prostate, lung, ovary, colon or uterus.

 The artificial intelligence program is able to read all the medical resources that are available to it, according to IBM, to help make the best decisions about specialized treatments for each patient.

For example, Watson can access information on more than 300 medical journals, 200 textbooks and about 15 million documentation on clinical cases in seconds.

In this way, the doctor can obtain the most relevant data for each specific case. However, this artificial intelligence, as demonstrated in Denmark, is still at an immature stage, as confirmed by some experts.

No comments:

Post a Comment